Literature DB >> 27896467

Audit of geriatric hip fracture care - a Slovenian trauma center analysis.

Dejan Krušič1, Drago Brilej2, Colin Currie3, Radko Komadina1.   

Abstract

BACKGROUND: The aim was to describe an audit of hip fracture patient care and outcomes in a Slovenian healthcare setting prior to the implementation of the Geriatric Fracture Center (GFC) model of care.
METHODS: The Fragility Fracture Network (FFN) hip fracture audit database was used to collect data on hip fracture care in elderly patients. Epidemiological data were submitted as well as fracture type, prefracture residence and mobility prior to the fracture. The timeline of events and acute care data were also collected. Follow-up after 30 days included hip-related readmission, mobility, residence and life status.
RESULTS: Included were 495 patients with a mean age of 81 years of which 20% were preoperatively seen by a physician or geriatrician, 93.1% had surgical repair, 58.5% of them within 48 h of admission. The mortality rate in hospital was 5.4% and 10.1% at follow-up, 61.8% patients were able to return to prefracture residency and 23% could walk with minor assistance.
CONCLUSION: This comprehensive and detailed audit report provides baseline data on case-mix, care and outcomes following hip fractures in Slovenia, in advance of planned quality improvement work in geriatric fracture care and provides a strong basis for the assessment of the impact of the GFC model of care.

Entities:  

Keywords:  Geriatrics; Hip fracture; Mortality; Outcome; Registry; Slovenia

Mesh:

Year:  2016        PMID: 27896467     DOI: 10.1007/s00508-016-1137-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  7 in total

1.  The Tyrolean Geriatric Fracture Center: an orthogeriatric co-management model.

Authors:  C Kammerlander; M Gosch; M Blauth; M Lechleitner; T J Luger; T Roth
Journal:  Z Gerontol Geriatr       Date:  2011-12-14       Impact factor: 1.281

2.  Outcomes of elderly hip fracture patients in the Swiss healthcare system: A survey prior to the implementation of DRGs and prior to the implementation ofa Geriatric Fracture Centre.

Authors:  Manuela Pretto; Rebecca Spirig; Raphael Kaelin; Vanessa Muri-John; Reto W Kressig; Norbert Suhm
Journal:  Swiss Med Wkly       Date:  2010-08-24       Impact factor: 2.193

3.  Early mortality after hip fracture: is delay before surgery important?

Authors:  Christopher G Moran; Russell T Wenn; Manoj Sikand; Andrew M Taylor
Journal:  J Bone Joint Surg Am       Date:  2005-03       Impact factor: 5.284

4.  Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset.

Authors:  S M White; I K Moppett; R Griffiths
Journal:  Anaesthesia       Date:  2014-01-15       Impact factor: 6.955

Review 5.  Osteoporosis in the European Union: a compendium of country-specific reports.

Authors:  A Svedbom; E Hernlund; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis
Journal:  Arch Osteoporos       Date:  2013-10-11       Impact factor: 2.617

6.  The impact of a national clinician-led audit initiative on care and mortality after hip fracture in England: an external evaluation using time trends in non-audit data.

Authors:  Jenny Neuburger; Colin Currie; Robert Wakeman; Carmen Tsang; Fay Plant; Bianca De Stavola; David A Cromwell; Jan van der Meulen
Journal:  Med Care       Date:  2015-08       Impact factor: 2.983

7.  Improving hip fracture care in ireland: a preliminary report of the irish hip fracture database.

Authors:  Prasad Ellanti; Breda Cushen; Adam Galbraith; Louise Brent; Conor Hurson; Emer Ahern
Journal:  J Osteoporos       Date:  2014-12-08
  7 in total
  1 in total

Review 1.  Differences in hip fracture care in Europe: a systematic review of recent annual reports of hip fracture registries.

Authors:  Maic Werner; Christian Macke; Manfred Gogol; Christian Krettek; Emmanouil Liodakis
Journal:  Eur J Trauma Emerg Surg       Date:  2021-10-08       Impact factor: 2.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.